Company Profile · Healthcare

Dashenlin Pharm Grp Co Ltd

603233 · Shanghai
Country
China
Employees
41,141
Buffett Score
82/100
Elite
Market capCN¥20.73B
Revenue (TTM)CN¥27.97B
EBITDACN¥2.49B
Profit margin4.88%
ROE17.04%
P/E (TTM)15.29
Forward P/E0
EPSCN¥1.19
Dividend yield5.05%
52-week rangeCN¥14.39 – CN¥21.78

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

DaShenLin Pharmaceutical Group Co., Ltd. engages in the manufacture, distribution, and retail of pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and tonic herbs, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.

No reports on this stock in your language yet.